<DOC>
	<DOCNO>NCT03089450</DOCNO>
	<brief_summary>evaluate safety efficacy CGBIO stent ( DES ) compare Biomatrix flex stent ( DES )</brief_summary>
	<brief_title>To Evaluate Safety Efficacy CGBIO Stent Compared Biomatrix Flex Stent</brief_title>
	<detailed_description>A Multicenter , subject-blinded , randomize study evaluate safety efficacy CGBIO stent compare Biomatrix Flex stent patient undergo drug-eluting stent procedure coronary angiography</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>At least one lesion diameter stenosis &gt; 50 % suitable coronary stent implantation vessel reference diameter range 2.5 mm 4.0 mm ; Gr 1 â‰¤TIMI flow STsegment elevation MI Bifurcation lesion Chronic total occulusion Restenosis lesion Graft vessel lesion Patient history bleed diathesis coagulopathy patient antiplatelet and/or anticoagulant therapy contraindicate patient able comply dual antiplatelet therapy least 1 year Cardiogenic shock hemodynamic compromise Existing impairment liver kidney .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>